136 related articles for article (PubMed ID: 3116081)
1. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.
Bussolino F; Camussi G; Aglietta M; Braquet P; Bosia A; Pescarmona G; Sanavio F; D'Urso N; Marchisio PC
J Immunol; 1987 Oct; 139(7):2439-46. PubMed ID: 3116081
[TBL] [Abstract][Full Text] [Related]
2. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.
Camussi G; Montrucchio G; Lupia E; De Martino A; Perona L; Arese M; Vercellone A; Toniolo A; Bussolino F
J Immunol; 1995 Jun; 154(12):6492-501. PubMed ID: 7539022
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor.
Zhang Y; Gu Y; Lucas MJ; Wang Y
J Soc Gynecol Investig; 2003 Jan; 10(1):5-10. PubMed ID: 12517587
[TBL] [Abstract][Full Text] [Related]
5. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
Breviario F; Bertocchi F; Dejana E; Bussolino F
J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor-induced alterations in vinculin distribution in porcine vascular smooth muscle cells.
Herman B; Roe MW; Harris C; Wray B; Clemmons D
Cell Motil Cytoskeleton; 1987; 8(2):91-105. PubMed ID: 3121190
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor.
Kimani G; Tonnesen MG; Henson PM
J Immunol; 1988 May; 140(9):3161-6. PubMed ID: 3361129
[TBL] [Abstract][Full Text] [Related]
8. Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture.
Stoll LL; Spector AA
J Cell Physiol; 1989 May; 139(2):253-61. PubMed ID: 2715186
[TBL] [Abstract][Full Text] [Related]
9. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
Beauchamp MH; Marrache AM; Hou X; Gobeil F; Bernier SG; Lachapelle P; Abran D; Quiniou C; Brault S; Peri KG; Roberts J; Almazan G; Varma DR; Chemtob S
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3327-37. PubMed ID: 12356842
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes.
von Asmuth EJ; Buurman WA
J Immunol; 1995 Feb; 154(3):1383-90. PubMed ID: 7529802
[TBL] [Abstract][Full Text] [Related]
13. Characterization of platelet-activating factor receptors on canine T lymphocytes.
Mangino MJ; Murphy MK; Weiss A; Anderson CB
J Immunol; 1993 Nov; 151(10):5310-8. PubMed ID: 8228226
[TBL] [Abstract][Full Text] [Related]
14. Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue.
McNeil RS; Swann JW; Brinkley BR; Clark GD
Cell Motil Cytoskeleton; 1999; 43(2):99-113. PubMed ID: 10379835
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) increases NO production in human endothelial cells-real-time monitoring by DAR-4M AM.
Kikuchi M; Shirasaki H; Himi T
Prostaglandins Leukot Essent Fatty Acids; 2008; 78(4-5):305-9. PubMed ID: 18502110
[TBL] [Abstract][Full Text] [Related]
16. Effect of platelet-activating factor receptor expression on CHO cell motility.
Boccellino M; Biancone L; Cantaluppi V; Ye RD; Camussi G
J Cell Physiol; 2000 May; 183(2):254-64. PubMed ID: 10737901
[TBL] [Abstract][Full Text] [Related]
17. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
Lee HT; Kay EP
Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia/reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism.
Franciose RJ; Moore EE; Moore FA; Read RA; Carl VS; Banerjee A
J Surg Res; 1996 Mar; 61(2):459-62. PubMed ID: 8656625
[TBL] [Abstract][Full Text] [Related]
19. Acute microcirculatory effects of platelet-activating factor.
Durán WN; Dillon PK
J Lipid Mediat; 1990; 2 Suppl():S215-27. PubMed ID: 2133284
[TBL] [Abstract][Full Text] [Related]
20. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
